Emergent BioSolutions
EBS
#6692
Rank
โ‚น46.75 B
Marketcap
โ‚น862.90
Share price
4.73%
Change (1 day)
413.01%
Change (1 year)

Revenue for Emergent BioSolutions (EBS)

Revenue in 2024 (TTM): โ‚น91.29 Billion

According to Emergent BioSolutions 's latest financial reports the company's current revenue (TTM ) is โ‚น94.70 Billion. In 2023 the company made a revenue of โ‚น85.16 Billion a decrease over the revenue in the year 2022 that were of โ‚น89.32 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Emergent BioSolutions from 2004 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น91.29 B7.2%
2023 โ‚น85.16 B-4.65%
2022 โ‚น89.32 B-27.64%
2021 โ‚น123.44 B17.19%
2020 โ‚น105.33 B50.19%
2019 โ‚น70.13 B42.21%
2018 โ‚น49.31 B57.49%
2017 โ‚น31.31 B33.41%
2016 โ‚น23.47 B-10.23%
2015 โ‚น26.14 B21.59%
2014 โ‚น21.50 B34.95%
2013 โ‚น15.93 B71.06%
2012 โ‚น9.31 B-35.59%
2011 โ‚น14.46 B12.78%
2010 โ‚น12.82 B17.71%
2009 โ‚น10.89 B26.94%
2008 โ‚น8.58 B19.55%
2007 โ‚น7.17 B-6.29%
2006 โ‚น7.66 B30.26%
2005 โ‚น5.88 B62.64%
2004 โ‚น3.61 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚น5.467 T 5,673.53%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น15.03 B-84.12%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.483 T 3,578.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น0.86 B-99.09%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น5.202 T 5,393.60%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.451 T 1,432.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚น10.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA